APT Medical Inc. (SHA:688617)
China flag China · Delayed Price · Currency is CNY
297.09
+5.59 (1.92%)
Jun 27, 2025, 2:45 PM CST

APT Medical Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Operating Revenue
2,1582,0491,6421,204822.86477.94
Upgrade
Other Revenue
16.6216.628.4911.555.821.5
Upgrade
2,1752,0661,6501,216828.69479.44
Upgrade
Revenue Growth (YoY)
23.86%25.18%35.71%46.74%72.85%18.68%
Upgrade
Cost of Revenue
604.32579.89486.14354.04259.08142.13
Upgrade
Gross Profit
1,5701,4861,164861.98569.61337.3
Upgrade
Selling, General & Admin
480.7464.34386.96307.57251.43152.5
Upgrade
Research & Development
298.89290.54237.92174.88134.8871.9
Upgrade
Other Operating Expenses
17.6715.2214.5213.758.146.14
Upgrade
Operating Expenses
800.29772.32639.21496.99393.93230.82
Upgrade
Operating Income
770.14713.59524.86364.99175.68106.48
Upgrade
Interest Expense
-2.46-2.01-3.69-1.45-1.63-0.83
Upgrade
Interest & Investment Income
27.1825.2327.7423.9413.261.21
Upgrade
Currency Exchange Gain (Loss)
2.832.832.661.17-1-0.43
Upgrade
Other Non Operating Income (Expenses)
-3.49-0.82-0.04-0.49-0.5-0.33
Upgrade
EBT Excluding Unusual Items
794.2738.83551.53388.16185.81106.09
Upgrade
Impairment of Goodwill
---3.84---
Upgrade
Gain (Loss) on Sale of Investments
-17.6-16.7-0.3421.72-0.07
Upgrade
Gain (Loss) on Sale of Assets
0.250.2511.970.060.02-0.23
Upgrade
Asset Writedown
-1.02-0.83-0.12-10.68-3.57-
Upgrade
Other Unusual Items
26.2724.4236.8317.2517.5815.42
Upgrade
Pretax Income
802.1745.97596.37395.13221.55121.21
Upgrade
Income Tax Expense
101.6687.874.2454.9826.717.02
Upgrade
Earnings From Continuing Operations
700.44658.17522.13340.16194.85104.19
Upgrade
Minority Interest in Earnings
15.7214.9811.7917.8613.076.58
Upgrade
Net Income
716.16673.15533.92358.02207.92110.78
Upgrade
Net Income to Common
716.16673.15533.92358.02207.92110.78
Upgrade
Net Income Growth
25.34%26.08%49.13%72.19%87.70%34.15%
Upgrade
Shares Outstanding (Basic)
140140140140137105
Upgrade
Shares Outstanding (Diluted)
141141142142138105
Upgrade
Shares Change (YoY)
-0.34%-0.52%-0.16%2.99%31.45%-0.29%
Upgrade
EPS (Basic)
5.104.803.822.561.521.06
Upgrade
EPS (Diluted)
5.084.773.772.521.511.06
Upgrade
EPS Growth
25.76%26.74%49.38%67.20%42.79%34.54%
Upgrade
Free Cash Flow
209.0493.15487.03224.2514.01104.04
Upgrade
Free Cash Flow Per Share
1.480.663.441.580.100.99
Upgrade
Dividend Per Share
1.2071.2070.9510.7850.4760.238
Upgrade
Dividend Growth
26.88%26.88%21.20%65.01%100.00%-
Upgrade
Gross Margin
72.21%71.93%70.54%70.88%68.74%70.35%
Upgrade
Operating Margin
35.41%34.54%31.81%30.01%21.20%22.21%
Upgrade
Profit Margin
32.93%32.58%32.36%29.44%25.09%23.11%
Upgrade
Free Cash Flow Margin
9.61%4.51%29.51%18.44%1.69%21.70%
Upgrade
EBITDA
851.95790.25580.9405.69203.49126.49
Upgrade
EBITDA Margin
39.17%38.25%35.20%33.36%24.56%26.38%
Upgrade
D&A For EBITDA
81.8176.6656.0440.727.8120
Upgrade
EBIT
770.14713.59524.86364.99175.68106.48
Upgrade
EBIT Margin
35.41%34.54%31.80%30.01%21.20%22.21%
Upgrade
Effective Tax Rate
12.67%11.77%12.45%13.91%12.05%14.04%
Upgrade
Revenue as Reported
2,1752,0661,6501,216828.69479.44
Upgrade
Updated Feb 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.